Skip to search formSkip to main contentSkip to account menu

TZP-101

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Ulimorelin Hyrdrochlorideulimorelin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset data
2010
2010
In brief
  • Nature Reviews Gastroenterology &Hepatology
  • 2010
  • Corpus ID: 2069494
2010
2010
475h TZP-101, a Potent Ghrelin Receptor Agonist, is Effective in Diabetic Patients With Delayed Gastric Emptying and Severe Nausea/Vomiting: Phase 2 Subset Study Data
2009
2009
Ghrelin Agonist TZP-101 Improves Symptoms and Gastric Emptying in Diabetic Patients with Gastroparesis: 2009 Presidential Poster
2008
2008
338 POSTER The ghrelin receptor agonist TZP-101 is a potent anti-tumor-cachexia agent in the human G361 melanoma mouse xenograft model
2008
2008
Gateways to clinical trials.
11D10, 9vPnC-MnCc; Adalimumab, Adefovir dipivoxil, Alefacept, ALN-RSV01, AME-133, AMG-317, Aminolevulinic acid methyl ester… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)